Durantoside I
CAS: 53526-67-3
Rif. 3D-DCA52667
| 1mg | Prezzo su richiesta | ||
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta |
Informazioni sul prodotto
- Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-4a,7-dihydroxy-7-methyl-6-[(1-oxo-3-phenyl-2-propenyl)oxy]-, methyl ester, [1S-(1α,4aα,6α,7α,7aα)]-
- Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-4a,7-dihydroxy-7-methyl-6-[(1-oxo-3-phenyl-2-propen-1-yl)oxy]-, methyl ester, (1S,4aR,6S,7R,7aS)-
- Cyclopenta[c]pyran-4-carboxylic acid, 1-(β-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-4a,7-dihydroxy-7-methyl-6-[(1-oxo-3-phenyl-2-propenyl)oxy]-, methyl ester, (1S,4aR,6S,7R,7aS)-
Durantoside I is a lippia extract that has been shown to have cancer-fighting properties. It is a flavonol glycoside acetate extract that has been purified by liquid chromatography. The compound was acetylated and the surface methodology was used for the extraction. The experimental model was cervical cancer and the preparation method was preparative high-performance liquid chromatography (HPLC). Durantoside I has been shown to inhibit cell growth, induce apoptosis, and suppress tumorigenesis in experimental models of cervical cancer.
Proprietà chimiche
Richiesta tecnica su: 3D-DCA52667 Durantoside I
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
